Lineage Cell Therapeutics (LCTX) Net Equity Issued and Repurchased (2010 - 2026)
Lineage Cell Therapeutics' Net Equity Issued and Repurchased came in at $5.39 million for Q1 2026, up 606.2% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
For FY2025, Lineage Cell Therapeutics' Net Equity Issued and Repurchased was $1.25 million, up 445.9% from FY2024.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -24.6% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $229,000 in FY2024 (+160.2%), $88,000 in FY2023 (-91.1%), $991,000 in FY2022 (-96.8%) and $30.87 million in FY2021 (+502.0%).
- The Q1 2026 figure represents the highest quarterly Net Equity Issued and Repurchased since Q2 2023.
- The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q1 2024 (growth of 158.8%), and the weakest in Q2 2022 (a decline of 99.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | - |
| 10 | Lineage Cell Therapeutics | 247.85 Mn | 46.25 Mn | - | 6,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,000.00 |
| Mar 31, 2026 | 5.62 Mn |
| Dec 31, 2025 | 763,000.00 |
| Sep 30, 2025 | 806,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 87,000.00 |
| Mar 31, 2024 | 132,000.00 |
| Dec 31, 2023 | -6.63 Mn |
| Sep 30, 2023 | 844,000.00 |
| Jun 30, 2023 | 5.82 Mn |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 131,000.00 |
| Sep 30, 2022 | 972,000.00 |
| Jun 30, 2022 | 106,000.00 |
| Mar 31, 2022 | 529,000.00 |
| Dec 31, 2021 | 974,000.00 |
| Sep 30, 2021 | 3.75 Mn |
| Jun 30, 2021 | 11.31 Mn |
| Mar 31, 2021 | 20.98 Mn |
| Dec 31, 2020 | -19.50 Mn |
API Access
Lineage Cell Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();